Prior studies addressing the possibility of molecular mimicry in MS found clonally expanded EBNA-1-specific CD4+ T-cells that potentially contributed to the development of MS by cross-recognition with myelin antigens (75, 101). Here, CD4 is linked to myeloid sarcoma.